<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of superficial burns requiring hospital admission</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of superficial burns requiring hospital admission</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Treatment of superficial burns requiring hospital admission</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mayer Tenenhaus, MD, FACS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hans-Oliver Rennekampff, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc G Jeschke, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H466087465"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Superficial injuries to the skin, most commonly thermal injuries, can often be managed in an outpatient setting. When large areas of skin are affected, specialized anatomic sites are involved, or when the patient's comorbidities complicate management, inpatient management, often at a burn center, is recommended. </p><p>Superficial burns are managed by maintaining a clean and moist wound healing environment and protecting the wound from shear, tearing, and further injury while promoting re-epithelialization. Dressings are chosen to help to manage wound drainage and are changed according to the manufacturer's recommendations (eg, daily, or every second or third day) [<a href="#rid1">1</a>]. </p><p>Superficial skin loss from other types of injury, such as chemical burns, or skin loss from toxic epidermal necrolysis (TEN) is managed using similar principles. However, there are several differences. As an example, superficial skin loss from TEN is characterized by wounds that are not often challenged by problems of exudate management but may suffer from complicated superinfection. In addition to wound care, the underlying pathophysiologic cause needs to be specifically addressed. Chemical burns may require additional therapies to neutralize deleterious local or systemic effects. (See  <a class="medical medical_review" href="/d/html/2092.html" rel="external">"Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae"</a> and  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a>.)</p><p>The management of patients with superficial skin loss requiring hospitalization (predominantly thermal burns), the management of potential complications, and follow-up care are reviewed here. </p><p>Treatment of minor burns (not requiring hospital admission) and treatment of deep partial-thickness and full-thickness burns are reviewed separately. (See  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns"</a> and  <a class="medical medical_review" href="/d/html/114178.html" rel="external">"Treatment of deep burns"</a>.) </p><p class="headingAnchor" id="H1878043147"><span class="h1">SUPERFICIAL BURNS</span><span class="headingEndMark"> — </span>Burns are classified and treated according to the depth of tissue injury (ie, superficial [epidermal], superficial partial-thickness, deep partial-thickness, full-thickness, and deeper burns)  (<a class="graphic graphic_table graphicRef61540" href="/d/graphic/61540.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/819.html" rel="external">"Assessment and classification of burn injury"</a> and  <a class="medical medical_review" href="/d/html/819.html" rel="external">"Assessment and classification of burn injury", section on 'Classification by depth'</a>.)</p><p>Superficial (epidermal) burns involve only the epidermal layer of skin. These do not blister but are painful, dry, red, and blanch with pressure  (<a class="graphic graphic_picture graphicRef55928" href="/d/graphic/55928.html" rel="external">picture 1</a>). This process is commonly seen with sunburns. Over two to three days the pain and erythema subside, and by approximately day 4, the injured epithelium peels away from the newly healed epidermis. Such injuries are generally healed in six days with conservative care without scarring. It is important to realize that burns that initially appear to be only epidermal in depth may be determined to be partial thickness (deeper) 12 to 24 hours later. Patients with extensive epidermal burns may require admission to manage significant pain, dehydration, or other associated challenges or social issues and comorbidities such as drug or alcohol use and neglect. Patients with sunburns are counseled as to prevention strategies, the potential for sun damage, detrimental actinic changes, and skin cancer concerns.</p><p>Partial-thickness burns, by definition, involve the epidermis and portions of the dermis. Partial-thickness burns can be superficial or deep, each of which require different therapy. It is often difficult to distinguish between superficial partial-thickness and deep partial-thickness burns immediately following the burn injury presentation. As a result, these burns must be reevaluated frequently during the first 72 hours. </p><p class="bulletIndent1"><span class="glyph">●</span>Superficial partial-thickness burns characteristically form blisters within 24 hours between the epidermis and dermis. They are painful, red, and weeping and blanch with pressure  (<a class="graphic graphic_picture graphicRef75398" href="/d/graphic/75398.html" rel="external">picture 2</a>). These burns generally heal in 7 to 21 days, and, though scarring is unusual, pigment changes can occur. Treatment of superficial partial-thickness burns generally consists of debridement, topical antimicrobial applications, and dressing changes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Deeper burns (deep partial-thickness and deep burns) generally require excision and skin grafting. Failure to identify which wounds require operative management can result in scar formation and contractures that may be debilitating [<a href="#rid2">2,3</a>]. The treatment of deep burn wounds is reviewed separately. (See  <a class="medical medical_review" href="/d/html/114178.html" rel="external">"Treatment of deep burns"</a>.)</p><p></p><p class="headingAnchor" id="H697594949"><span class="h1">ASSESSMENT FOR INPATIENT CARE</span><span class="headingEndMark"> — </span>An accurate assessment of burn depth and extent of total body surface area (TBSA) burned is an essential determinant of the decision as to whether or not inpatient care is required. Only minor burns, as defined by the American Burn Association and American College of Surgeons, should be treated on an outpatient basis [<a href="#rid4">4,5</a>]. (See  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns"</a>.)</p><p>Inpatient hospital care, ideally at a burn center  (<a class="graphic graphic_table graphicRef74855" href="/d/graphic/74855.html" rel="external">table 2</a>), is mandated for any patient with any burn who has at least one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Comorbid illness </p><p class="bulletIndent1"><span class="glyph">●</span>Questionable patient reliability</p><p class="bulletIndent1"><span class="glyph">●</span>Noncompliance</p><p class="bulletIndent1"><span class="glyph">●</span>Suspected or known abuse</p><p></p><p>Inpatient treatment is also indicated for patients who do not meet criteria for a minor burn (ie, &gt;10 percent TBSA burn [teens and adults]; &gt;5 percent TBSA burn [children and older adults]; associated with multiple trauma; involvement of the face, hands, perineum, or feet; crosses a major joint; or circumferential burn). (See  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns", section on 'Criteria for minor burns and specialty referral'</a> and <a class="local">'Special anatomic sites'</a> below.).</p><p>The treatment of superficial burns (epidermal or superficial partial-thickness) must address a number of issues, particularly local treatment of the burn, which may vary with the anatomic site of the burn, as well as systemic therapies to prevent complications.</p><p class="headingAnchor" id="H3680292106"><span class="h1">INITIAL CARE</span><span class="headingEndMark"> — </span>Systemic therapies include tetanus immunization, pain management, and, in selected patients, systemic antibiotics.</p><p>Tetanus immunization should be updated, and tetanus immunoglobulin should be given to patients who have not received complete primary immunization. (See  <a class="medical medical_review" href="/d/html/349.html" rel="external">"Treatment of minor thermal burns", section on 'Chemoprophylaxis'</a> and  <a class="medical medical_review" href="/d/html/3897.html" rel="external">"Tetanus-diphtheria toxoid vaccination in adults"</a>.) </p><p class="headingAnchor" id="H2893372665"><span class="h2">Pain management</span><span class="headingEndMark"> — </span>The wound care and physical therapy regimens associated with the treatment of superficial and intermediate-depth burns can be extremely painful. </p><p>Smaller burn wounds can be treated with maintenance doses of <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> and nonsteroidal anti-inflammatory drugs, alone or in combination with oral opioids [<a href="#rid6">6-9</a>]. For breakthrough pain during dressing changes or physical therapy, additional opioids and anxiolytics may be used. Patients treated with multidrug regimens should be monitored for adverse interactions and respiratory compromise. Topically applied or locally injected anaesthetics are <strong>not</strong> recommended because of increased toxicity and variable absorption. (See  <a class="medical medical_review" href="/d/html/130312.html" rel="external">"Approach to the management of acute pain in adults"</a>.)</p><p>Severe pain associated with larger total body surface area (TBSA) burns typically requires intravenous opioids. Patient-controlled analgesia can be used for patients who are awake, alert, and have the dexterity necessary to safely and effectively use these devices. Supplemental analgesia and sedation are often required during interventions. (See  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching", section on 'Pharmacologic treatment options'</a>.)</p><p>Inpatient dressing changes and manipulations often require intravenous combination strategies for sedation and analgesia. Medications like <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a>, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>, and <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> are commonly employed. These medications require close monitoring with pulse oximetry. (See  <a class="medical medical_review" href="/d/html/16505.html" rel="external">"Paradigm-based treatment approaches for management of burn pain", section on 'Paradigm-based management'</a>.)</p><p>Longer-acting pain medications (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> patches and <a class="drug drug_general" data-topicid="9623" href="/d/drug information/9623.html" rel="external">methadone</a>) are reserved for the management of chronic rather than acute pain. For difficult-to-control post-burn chronic pain, consultation with a pain management service is advised. (See  <a class="medical medical_review" href="/d/html/126111.html" rel="external">"Approach to the management of chronic non-cancer pain in adults"</a>.)</p><p class="headingAnchor" id="H3665569912"><span class="h2">Parenteral antibiotics</span><span class="headingEndMark"> — </span>Prophylactic systemic antibiotics are not recommended for patients with small-to-moderate-percent TBSA superficial partial-thickness burns [<a href="#rid10">10,11</a>]. For superficial partial-thickness burns that involve more than 40 percent TBSA, it is unclear if there is any benefit to antimicrobial prophylaxis [<a href="#rid11">11</a>]. </p><p>The treatment of burn wound infection requires systemic antimicrobial therapy and is reviewed separately. (See <a class="local">'Assessing for burn wound infection'</a> below and  <a class="medical medical_review" href="/d/html/14985.html" rel="external">"Burn wound infection and sepsis"</a>.)</p><p class="headingAnchor" id="H1675764859"><span class="h1">LOCAL BURN CARE</span><span class="headingEndMark"> — </span>Burn wound healing is a dynamic process, and local management must address the evolving clinical picture.<strong> </strong>Acute burn wounds should, if available, be evaluated and treated by an experienced burn care provider. Conservative, nonoperative therapies include cleansing, debridement, and dressing changes using any of a number of topical antimicrobial agents and wound coverings.</p><p class="headingAnchor" id="H2887591563"><span class="h2">Our approach</span><span class="headingEndMark"> — </span>After the initial assessment and cleansing, superficial burn wounds without signs of infection can be covered with dressing materials that aid with skin healing and reepithelialization. There is no consensus on which topical agent or dressing is best suited for these burn wounds. A review of 26 randomized trials (most with methodologic shortcomings) did not identify an optimal dressing type [<a href="#rid12">12,13</a>]. </p><p>In general, superficial (epidermal) burns do not require antimicrobial therapy, but for extensive superficial (epidermal or superficial partial-thickness) burns, topical antimicrobials may be used to prevent colonization while maintaining a moist wound healing environment. Furthermore, because superficial partial-thickness burns may not always be easily distinguished from deeper injuries, topical antimicrobial agents are often used. For superficial burns, we suggest starting with a combination antibiotic ointment or creme (eg, Polysporin) covered with a nonadherent dressing (eg, Xeroform or Adaptic). When in close proximity to the eyes, we use an ophthalmic ointment without steroids.</p><p>Clean and still moist wounds, particularly when they occur in the pediatric patient population, or in functional and aesthetic regions such as the face, hands, feet, and chest, are often definitively managed using biologic or biosynthetic dressings. (See <a class="local">'Burn wound dressings and topical therapy'</a> below.)</p><p class="headingAnchor" id="H3403924161"><span class="h2">Cleansing and debridement</span><span class="headingEndMark"> — </span>Cleansing and debridement removes loose, devitalized, and necrotic tissue (eg, blister, foreign material, and debris). Debrided wounds have a greater tendency to heal in a timely fashion as compared with nondebrided wounds [<a href="#rid1">1</a>]. After judicious debridement, the wound site may be treated with a topical antimicrobial agent or nonadherent dressing regimen.</p><p>Initially, burn wounds are gently and carefully cleansed and then reevaluated. Cleansing can be performed using skin disinfectants or mild soap and water. An additional debridement is generally performed using gentle mechanical techniques (eg, brushing, scraping, curetting, and cutting). In our practice, we generally prefer to begin with well-moistened soft gauze or cotton laparotomy pads. When more aggressive debridement is required, we will often use well-moistened <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> surgical scrub brushes.</p><p>A variety of proteolytic enzymes (eg, <a class="drug drug_general" data-topicid="16759" href="/d/drug information/16759.html" rel="external">collagenase</a>, bromelain) have been selectively used to debride burn wounds without damage to the normal tissue [<a href="#rid14">14,15</a>]. These products may be beneficial when removing eschar and pseudoeschar. (See  <a class="medical medical_review" href="/d/html/15912.html" rel="external">"Basic principles of wound management", section on 'Enzymatic'</a>.)</p><p>Proteolytic agents should <strong>not</strong> be used in infected sites or in areas where there is a risk of ocular contamination. In addition, some patients develop allergic reactions. While treatment of burns with enzymatic debridement is safe [<a href="#rid16">16</a>], results are highly variable [<a href="#rid15">15,17</a>].</p><p class="headingAnchor" id="H1330330079"><span class="h3">Burn blisters</span><span class="headingEndMark"> — </span>The management of burn blisters depends, in part, upon whether the blister has ruptured. Ruptured blisters should be debrided. The best treatment for an intact burn blister remains a matter of debate [<a href="#rid18">18</a>]. There is no universal standard of practice regarding intact burn blisters, and, in the absence of good data, experts may come to differing conclusions. As an example, some feel that there is an increased risk of infection in intact blisters, while others feel that the blister acts as a barrier to infection.</p><p>Potential reasons to rupture intact blisters include:</p><p class="bulletIndent1"><span class="glyph">●</span>Large and expanding blisters may exert pressure onto the underlying wound surface.</p><p class="bulletIndent1"><span class="glyph">●</span>Large blisters can impair range of motion or movement (eg, hand, fingers, foot, toe).</p><p class="bulletIndent1"><span class="glyph">●</span>Intact blisters can hinder the accurate assessment of burn depth.</p><p class="bulletIndent1"><span class="glyph">●</span>The risk of infection is increased in intact blisters.</p><p class="bulletIndent1"><span class="glyph">●</span>Components of blister fluid are harmful to wound healing.</p><p></p><p>Potential reasons for preserving a burn blister include:</p><p class="bulletIndent1"><span class="glyph">●</span>Blisters form a natural barrier against infection.</p><p class="bulletIndent1"><span class="glyph">●</span>Blister fluid provides wound healing benefits.</p><p class="bulletIndent1"><span class="glyph">●</span>A wound may become desiccated in the absence of adequate dressings and topical antimicrobial agents. </p><p></p><p class="headingAnchor" id="H3940153255"><span class="h2">Burn wound dressings and topical therapy</span><span class="headingEndMark"> — </span>After the initial assessment and cleansing, superficial partial-thickness burn wounds can be covered using a variety of dressing materials that aid with skin healing and re-epithelialization. There is no consensus on which topical agent or dressing is best suited for burn wound management [<a href="#rid12">12,13</a>]. Dressing changes should be frequent enough to control exudate but not so frequent as to interfere with wound re-epithelialization. Re-epithelialization can be disturbed by very frequent dressing changes. A delicate balance must be achieved between a clean wound and delayed wound healing. </p><p>Commonly used topical agents for partial-thickness burns include <a class="drug drug_general" data-topicid="9052" href="/d/drug information/9052.html" rel="external">bacitracin</a>, polymyxin, <a class="drug drug_general" data-topicid="9686" href="/d/drug information/9686.html" rel="external">neomycin</a>, silver-containing agents, <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a>, povidone-iodine, <a class="drug drug_general" data-topicid="9579" href="/d/drug information/9579.html" rel="external">mafenide</a>, and petroleum-impregnated gauze [<a href="#rid10">10,12</a>]. These agents have variable degrees of local or systemic adverse effects and can impede wound healing  (<a class="graphic graphic_table graphicRef81801" href="/d/graphic/81801.html" rel="external">table 3</a>) [<a href="#rid1">1,19</a>]. (See  <a class="medical medical_review" href="/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Antimicrobial agents'</a>.)</p><p>Other forms of burn wound coverage can be used for superficial partial-thickness burns. Hydrocolloid dressings, silicone-coated polyurethane dressings, cellulose, or silk are advocated for the treatment of superficial and partial-thickness burns that comprise a limited body surface area. Hydrocolloid dressings, which provide a moist environment, may be more beneficial in the later phase of reepithelialization. For antimicrobial activity, some materials contain silver. Silver dressings (eg, Acticoat) can also be used as a primary dressing. The mechanism of action and efficacy of these agents are reviewed separately. (See  <a class="medical medical_review" href="/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Dressings'</a>.)</p><p>Biologic dressing such as placental-derived products (eg, AmnioExcel, Amnioburn, EpiBurn) or biosynthetic dressings (eg, Suprathel, PermeaDerm) are skin substitutes that are used as temporary dressings. These may improve comfort of the burn patient by reducing the number of dressing changes [<a href="#rid20">20,21</a>]. The type of skin substitute to use depends on the appearance of the wound, desired outcome, cost efficacy, availability, and the clinician's experience, as well as cultural preferences. In a review of 20 prospective trials, for the treatment of partial-thickness burns, skin substitutes were at least as efficacious as topical agents/wound dressings or allografts [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Biologic grafts'</a> and  <a class="medical medical_review" href="/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Semibiologic skin substitutes'</a> and  <a class="medical medical_review" href="/d/html/118064.html" rel="external">"Skin substitutes"</a>.)</p><p>An autologous cell harvesting device can prepare an epidermal suspension (ie, ReCell), which is directly applied to acute partial-thickness burn wounds or applied in combination with meshed autografts [<a href="#rid23">23</a>]. While this preparation has been used in combination with other dressing (eg, Suprathel) with reports of improved healing, the evidence for this over dressings alone is lacking but will likely be addressed in future trials [<a href="#rid24">24</a>]. ReCell has been approved for use by the US Food and Drug Administration for direct application to acute partial-thickness thermal burn wounds in patients 18 years and older.</p><p class="headingAnchor" id="H3907864123"><span class="h2">Special anatomic sites</span><span class="headingEndMark"> — </span>Superficial partial-thickness burns to the face, hands, perineum, genitalia, and feet require special attention and should be carefully evaluated for nonoperative management. Patients with burns in these areas should be cared for at a burn center.</p><p class="headingAnchor" id="H3681674088"><span class="h3">Face</span><span class="headingEndMark"> — </span>Superficial partial-thickness burns to the face are best managed by daily gentle washes, followed by the application of a topical cytoprotective or moisturizing agent. Excessive drying or desiccation of the wound should be avoided. A gentle debridement and/or the adjunctive use of an enzymatic debriding agent removes accumulated proteinaceous material or pseudoeschar and promotes re-epithelialization. Skin substitutes can be used in facial burns, especially intermediate partial-thickness wounds [<a href="#rid25">25,26</a>]. Burn wounds that do not heal within 14 to 21 days require surgical or chemical treatment. (See  <a class="medical medical_review" href="/d/html/15318.html" rel="external">"Principles of burn reconstruction: Face, scalp, and neck"</a>.)</p><p class="headingAnchor" id="H1397929245"><span class="h3">Ears</span><span class="headingEndMark"> — </span>There is little protection or insulation of the cartilage from injury because the ear lacks a subcutaneous layer. Chondritis, a painful and destructive process of the cartilage, occurs in 5 to 25 percent of all burned ears and is the most common complication [<a href="#rid27">27</a>]. Burns to the ear are managed conservatively with shaving the hair around the ear, daily cleansing, and application of a topical ointment [<a href="#rid27">27</a>]. Topical antimicrobial ointments, such as <a class="drug drug_general" data-topicid="9579" href="/d/drug information/9579.html" rel="external">mafenide</a> acetate, are advocated to prevent the conversion of superficial partial-thickness burns to a deeper burn [<a href="#rid28">28</a>]. External pressure to the ear should be avoided, and operative intervention should be judiciously used. (See  <a class="medical medical_review" href="/d/html/15318.html" rel="external">"Principles of burn reconstruction: Face, scalp, and neck", section on 'Ear'</a>.)</p><p class="headingAnchor" id="H2413432156"><span class="h3">Ocular area</span><span class="headingEndMark"> — </span>Burns to the eyelid, periorbital region, sclera, conjunctiva, and cornea are considered ocular burns and should always be assessed in facial burns. Ocular burn severity is directly correlated to duration of exposure and causative agent [<a href="#rid29">29</a>]. Ocular burns represent 7 to 18 percent of all ocular traumas [<a href="#rid30">30</a>]. For burns that result from a chemical injury, the eyes should be immediately and copiously irrigated with sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> solution. A topical anesthetic can be inserted into the eye to facilitate irrigation. Ocular burns should be treated with non-steroid-containing topical antimicrobial ointments to the eye and eyelid if burned. Cool saline compresses can be applied to the eyelids, and burned eyelashes and eschar may need to be removed. An eye patch may be needed in the case of a thermal injury or lid retraction from a splash injury. <a class="drug drug_general" data-topicid="8660" href="/d/drug information/8660.html" rel="external">Artificial tears</a> are needed if the lacrimal ducts are burned. Pain relief should be addressed, and an ophthalmologic consultation should be obtained. (See  <a class="medical medical_review" href="/d/html/15318.html" rel="external">"Principles of burn reconstruction: Face, scalp, and neck", section on 'Ocular'</a>.)</p><p class="headingAnchor" id="H3592184299"><span class="h3">Hands</span><span class="headingEndMark"> — </span>Burns to the hand, like those involving all critical aesthetic and functional areas, require special attention [<a href="#rid31">31-33</a>]. Due to the unique anatomy of the palmar skin, most burns to the palmar surface in adults and children can be managed conservatively. A retrospective review of 168 pediatric patients with palm burns found that 87 percent healed with conservative, nonoperative management and only four of those palms (2.4 percent) required late reconstruction [<a href="#rid34">34</a>]. However, the skin overlying the dorsum of the hand is much thinner. The underlying and more superficially positioned joints and tendons require early excision and coverage with either skin grafts or a tissue flap. (See  <a class="medical medical_review" href="/d/html/825.html" rel="external">"Primary operative management of hand burns"</a>.) </p><p class="headingAnchor" id="H3570292296"><span class="h3">Feet</span><span class="headingEndMark"> — </span>Burns to the feet may require special attention because of difficulties in self-management of the wound. As in the case of palmar hand burns, superficial burns to the thick and heavily keratinized sole will, in most instances, heal well when treated conservatively with daily cleansing, followed by gauze-based, nonadherent, or antimicrobial dressings. (See  <a class="medical medical_review" href="/d/html/15538.html" rel="external">"Principles of burn reconstruction: Extremities and regional nodal basins", section on 'Foot and toes'</a>.)</p><p class="headingAnchor" id="H1272740303"><span class="h3">Perineum</span><span class="headingEndMark"> — </span>Burns to the perineum will also necessitate special attention with daily cleansing and antimicrobial dressings [<a href="#rid35">35</a>]. Catheter drainage systems are generally not required for most superficial burns; however, pain on voiding due to periurethral involvement or the necessity for monitoring the adequacy of resuscitation or urinary output might require catheter placement. (See  <a class="medical medical_review" href="/d/html/15439.html" rel="external">"Principles of burn reconstruction: Perineum and genitalia"</a>.)</p><p class="headingAnchor" id="H2856446158"><span class="h2">Reassessment of burn wounds</span></p><p class="headingAnchor" id="H2996359951"><span class="h3">Burn wound depth</span><span class="headingEndMark"> — </span>Wound depth may evolve from superficial to deep; hence, early reassessment over the ensuing 72 hours is important. Assessment should continue over 7 to 14 days, as needed. Deep burn wounds will require a different treatment. (See  <a class="medical medical_review" href="/d/html/114178.html" rel="external">"Treatment of deep burns"</a> and  <a class="medical medical_review" href="/d/html/14990.html" rel="external">"Overview of surgical procedures used in the management of burn injuries", section on 'Skin grafting'</a>.)</p><p>Laser Doppler imaging has been used for evaluation of depth of injury in burn wounds and may be able to predict healing by discriminating various depths of injury [<a href="#rid36">36,37</a>].</p><p class="headingAnchor" id="H2717850281"><span class="h3">Assessing for burn wound infection</span><span class="headingEndMark"> — </span>Immediately following a burn injury, the surface of the burn wound is free of microorganisms. Over the subsequent days following the burn, the wound is colonized from various sources [<a href="#rid2">2,11</a>]. (See  <a class="medical medical_review" href="/d/html/14985.html" rel="external">"Burn wound infection and sepsis", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/d/html/14985.html" rel="external">"Burn wound infection and sepsis", section on 'Microbiology'</a>.)</p><p>Clinical correlation and expertise are required to distinguish between bacterial colonization of the burn wound, which is frequent, and an invasive infection, which requires systemic treatment. The clinical features of noninvasive burn wound infection and invasive burn wound infection are reviewed separately. (See  <a class="medical medical_review" href="/d/html/14985.html" rel="external">"Burn wound infection and sepsis", section on 'Burn wound appearance'</a>.)</p><p>In summary: </p><p class="bulletIndent1"><span class="glyph">●</span>Noninvasive burn wound infection is present when there are typical clinical features of infection without systemic signs and the bacterial count is &gt;10<sup>5</sup> bacteria per gram of tissue (or recovery of mold or yeast by culture) obtained from a burn wound or eschar with <strong>no</strong> invasive component (ie, no microbial invasion into unburned tissue) as identified by tissue histopathology. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Invasive burn wound infection is present when there are typical clinical features consistent with burn wound infection associated with systemic signs and bacterial count is &gt;10<sup>5</sup> bacteria per gram of tissue obtained from a burn wound or eschar <strong>with</strong> an invasive component (ie, microbial or fungal invasion into unburned tissue) identified by tissue histopathology. </p><p></p><p>Systemic antimicrobial therapy is required to treat a burn wound infection and is based on quantitative wound cultures and microbial sensitivity. Aggressive surgical management of the local wound requires thorough cleansing and debridement, and dressing coverage. (See  <a class="medical medical_review" href="/d/html/14985.html" rel="external">"Burn wound infection and sepsis", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H698052295"><span class="h1">OUTPATIENT FOLLOW-UP MANAGEMENT</span><span class="headingEndMark"> — </span>Patients with superficial burns may be discharged with wounds that have not completely re-epithelialized. These patients must be closely monitored and followed in the outpatient clinic to: </p><p class="bulletIndent1"><span class="glyph">●</span>Assess the adequacy of pain control and manage pruritus</p><p class="bulletIndent1"><span class="glyph">●</span>Reassess the depth of the burn wound and address the evolving state of the wound</p><p class="bulletIndent1"><span class="glyph">●</span>Assess the appropriateness of the wound care regimen</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate patient compliance</p><p></p><p>Similarly, for superficial burns treated in the emergency department or as an outpatient, we suggest reexamination by a surgical burn specialist as soon as feasible.</p><p class="headingAnchor" id="H2684074424"><span class="h2">Burn wound pruritus</span><span class="headingEndMark"> — </span>Pruritus is often reported by the burn survivor. Pruritus tends to present early during wound healing process and continues well after re-epithelialization and scar maturation. It usually diminishes over time and rarely persists beyond 18 months. </p><p>First-line treatment includes oral antihistamines such as <a class="drug drug_general" data-topicid="9369" href="/d/drug information/9369.html" rel="external">diphenhydramine</a> hydrochloride. Other agents that may be helpful include H1 and H2 blockers, <a class="drug drug_general" data-topicid="9311" href="/d/drug information/9311.html" rel="external">cyproheptadine</a>, <a class="drug drug_general" data-topicid="8544" href="/d/drug information/8544.html" rel="external">hydroxyzine</a>, and tricyclic antidepressants (<a class="drug drug_general" data-topicid="9390" href="/d/drug information/9390.html" rel="external">doxepin</a>) as well as various topical agents [<a href="#rid38">38</a>]. Preparations high in <a class="drug drug_general" data-topicid="101844" href="/d/drug information/101844.html" rel="external">lanolin</a> should be avoided, as they can worsen the problem. (See  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching", section on 'Treatment of pruritus'</a>.)</p><p>There are some inherent risks with the topical application of steroids to burn wounds, including thinning of the healing skin, infection, and systemic absorption. Use of <a class="drug drug_general" data-topicid="8535" href="/d/drug information/8535.html" rel="external">hydrocortisone</a> is limited in many burn centers. Do not exceed recommended dosing, and limit the surface area treated. </p><p class="headingAnchor" id="H1848206069"><span class="h2">Restoring form and function</span><span class="headingEndMark"> — </span>Restoration of form and function, as well as return to home, work, and activities of daily living, are important goals and determinants for adequacy of treatment. </p><p>The follow-up plan should include:</p><p class="bulletIndent1"><span class="glyph">●</span>Restoring range of motion and strength of a burned extremity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining durability of the repaired burn wound.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Local skin care.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Scar modification, if needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Desensitization strategies to assist the burn victim in coping with the trauma. The importance of psychosocial support cannot be overemphasized. </p><p></p><p>It is very common for small trauma, sheer stresses, and local injuries to cause traumatic blisters and wounds in the recently re-epithelialized wounds. Bonding of the epidermis and dermis is fragile and will gain strength over time. Ruptured blisters can be managed with a nonadherent gauze dressing, a topically applied antimicrobial dressing, or a hydrocolloid dressing.</p><p>Burn patients should be referred to a surgeon with expertise in burn care if complete or near-complete reepithelialization takes longer than three to four weeks, as well as at the first sign of hypertrophic scarring. The development of hypertrophic scarring occurs in wounds that require more than 21 days to heal. The application of pressure garments is often advocated for our patients, as are massage and moisturization [<a href="#rid39">39</a>]. For established hypertrophic scars, silicone sheeting is also often recommended. Patients who develop functional or disfiguring scarring should be treated by a surgeon experienced in burn care. (See  <a class="medical medical_review" href="/d/html/95111.html" rel="external">"Hypertrophic scarring and keloids following burn injuries"</a>.) </p><p class="headingAnchor" id="H1599759856"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117752.html" rel="external">"Society guideline links: Care of the patient with burn injury"</a>.)</p><p class="headingAnchor" id="H900105426"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Superficial burns</strong> – It is important to distinguish between superficial (ie, superficial [epidermal], superficial partial-thickness) burns from deeper burns  (<a class="graphic graphic_table graphicRef61540" href="/d/graphic/61540.html" rel="external">table 1</a>). Superficial burns are treated conservatively with debridement, topical agents, and dressing changes while deeper burns require excision and skin grafting. Wound depth can evolve from superficial to deep; thus, reassessment is important. (See <a class="local">'Reassessment of burn wounds'</a> above and  <a class="medical medical_review" href="/d/html/114178.html" rel="external">"Treatment of deep burns"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Criteria for inpatient management</strong> – Patients with extensive superficial burns, particularly those with comorbid illness, or with questionable patient reliability, noncompliance, suspected or known abuse, or involvement of special anatomic sites, require inpatient evaluation and treatment. (See <a class="local">'Assessment for inpatient care'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Topical agents</strong> – There is no consensus on which topical agent or dressing is best suited for burn wound management. In the absence of high-quality data comparing agents, the choice can be made based on burn wound characteristics, phase of burn wound healing, frequency of dressing changes, provider familiarity, local availability, and cost. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In general, superficial (epidermal) burns do not require antimicrobial therapy, but for extensive superficial (epidermal or superficial partial-thickness) burns, topical antimicrobials may be used to prevent colonization while maintaining a moist wound healing environment. Furthermore, because superficial partial-thickness burns may not always be easily distinguished from deeper injuries, topical antimicrobial agents are often used. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For superficial burns, we suggest starting with a combination antibiotic ointment or creme (eg, Polysporin) covered with a nonadherent dressing (eg, Xeroform or Adaptic) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). When in proximity to the eyes, we use an ophthalmic ointment without steroids. (See  <a class="medical medical_review" href="/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Antimicrobial agents'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dressings</strong> – Dressing changes should be frequent enough to control exudate but not so frequent as to interfere with wound reepithelialization. It appears best to change dressings whenever they become soaked with excessive exudate or other fluids or if there are signs of infection. (See <a class="local">'Burn wound dressings and topical therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pain and itching</strong> – A variety of oral medications are used to treat burn wound pain and post-burn pruritus. Topical agents are also available to treat pruritus. (See <a class="local">'Burn wound pruritus'</a> above and  <a class="medical medical_review" href="/d/html/14989.html" rel="external">"Management of burn wound pain and itching", section on 'Treatment of pruritus'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient referral</strong> – For patients with superficial burns not initially managed at a burn center, referral to a surgeon with expertise in burn care should be made if complete or near complete re-epithelialization takes longer than three to four weeks, as this is a risk factor for hypertrophic scarring. (See <a class="local">'Restoring form and function'</a> above and  <a class="medical medical_review" href="/d/html/95111.html" rel="external">"Hypertrophic scarring and keloids following burn injuries"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Hartford CE, Kealey GP. Care of outpatient burns. In: Total Burn Care, Third edition, Herndon, DN (Eds), 2007. p.67.</li><li><a class="nounderline abstract_t">Deitch EA, Wheelahan TM, Rose MP, et al. Hypertrophic burn scars: analysis of variables. J Trauma 1983; 23:895.</a></li><li><a class="nounderline abstract_t">Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns 2006; 32:992.</a></li><li><a class="nounderline abstract_t">Hospital and prehospital resources for optimal care of patients with burn injury: guidelines for development and operation of burn centers. American Burn Association. J Burn Care Rehabil 1990; 11:98.</a></li><li class="breakAll">Committee on Trauma. Guidelines for the operation of burn units. In: Resources for Optimal Care of the Injured Patient, American College of Surgeons, Chicago 1999. p.38.</li><li><a class="nounderline abstract_t">Connor-Ballard PA. Understanding and managing burn pain: part 1. Am J Nurs 2009; 109:48.</a></li><li><a class="nounderline abstract_t">Connor-Ballard PA. Understanding and managing burn pain: Part 2. Am J Nurs 2009; 109:54.</a></li><li><a class="nounderline abstract_t">Romanowski KS, Carson J, Pape K, et al. American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps. J Burn Care Res 2020; 41:1129.</a></li><li class="breakAll">Meyer III WJ, Patterson DR, Jaco M, et al. Management of pain and other discomforts in burned patients. In: Total Burn Care, 3rd ed, Herndon DN (Ed), Saunders Elsevier, 2007 2007. p.797.</li><li><a class="nounderline abstract_t">Palmieri TL, Greenhalgh DG. Topical treatment of pediatric patients with burns: a practical guide. Am J Clin Dermatol 2002; 3:529.</a></li><li class="breakAll">http://emedicine.medscape.com/article/213595-overview (Accessed on June 13, 2010).</li><li><a class="nounderline abstract_t">Wasiak J, Cleland H. Topical negative pressure (TNP) for partial thickness burns. Cochrane Database Syst Rev 2007; :CD006215.</a></li><li><a class="nounderline abstract_t">Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev 2008; :CD002106.</a></li><li><a class="nounderline abstract_t">Neely AN, Brown RL, Clendening CE, et al. Proteolytic activity in human burn wounds. Wound Repair Regen 1997; 5:302.</a></li><li><a class="nounderline abstract_t">Klasen HJ. A review on the nonoperative removal of necrotic tissue from burn wounds. Burns 2000; 26:207.</a></li><li><a class="nounderline abstract_t">Rosenberg L, Lapid O, Bogdanov-Berezovsky A, et al. Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report. Burns 2004; 30:843.</a></li><li><a class="nounderline abstract_t">Ozcan C, Ergün O, Celik A, et al. Enzymatic debridement of burn wound with collagenase in children with partial-thickness burns. Burns 2002; 28:791.</a></li><li><a class="nounderline abstract_t">Sargent RL. Management of blisters in the partial-thickness burn: an integrative research review. J Burn Care Res 2006; 27:66.</a></li><li><a class="nounderline abstract_t">D'Avignon LC, Saffle JR, Chung KK, Cancio LC. Prevention and management of infections associated with burns in the combat casualty. J Trauma 2008; 64:S277.</a></li><li><a class="nounderline abstract_t">Kesting MR, Wolff KD, Hohlweg-Majert B, Steinstraesser L. The role of allogenic amniotic membrane in burn treatment. J Burn Care Res 2008; 29:907.</a></li><li><a class="nounderline abstract_t">Ramakrishnan KM, Jayaraman V. Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns 1997; 23 Suppl 1:S33.</a></li><li><a class="nounderline abstract_t">Pham C, Greenwood J, Cleland H, et al. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 2007; 33:946.</a></li><li><a class="nounderline abstract_t">Peirce SC, Carolan-Rees G. ReCell® Spray-On Skin System for Treating Skin Loss, Scarring and Depigmentation after Burn Injury: A NICE Medical Technology Guidance. Appl Health Econ Health Policy 2019; 17:131.</a></li><li><a class="nounderline abstract_t">Bairagi A, Griffin B, Tyack Z, et al. Comparative effectiveness of Biobrane®, RECELL® Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol. Burns Trauma 2019; 7:33.</a></li><li><a class="nounderline abstract_t">Klein MB, Moore ML, Costa B, Engrav LH. Primer on the management of face burns at the University of Washington. J Burn Care Rehabil 2005; 26:2.</a></li><li><a class="nounderline abstract_t">Leon-Villapalos J, Jeschke MG, Herndon DN. Topical management of facial burns. Burns 2008; 34:903.</a></li><li><a class="nounderline abstract_t">Kamel A, Kamel Ah, El Oteify M. Early management of the burned auricle. Annals of Burns and Fire Disasters 2004; 17:197.</a></li><li><a class="nounderline abstract_t">Skedros DG, Goldfarb IW, Slater H, Rocco J. Chondritis of the burned ear: a review. Ear Nose Throat J 1992; 71:359.</a></li><li class="breakAll">http://emedicine.medscape.com/article/798696-overview (Accessed on June 02, 2010).</li><li><a class="nounderline abstract_t">Merle H, Gérard M, Schrage N. [Ocular burns]. J Fr Ophtalmol 2008; 31:723.</a></li><li><a class="nounderline abstract_t">Lou RB, Hickerson WL. The use of skin substitutes in hand burns. Hand Clin 2009; 25:497.</a></li><li><a class="nounderline abstract_t">Kamolz LP, Kitzinger HB, Karle B, Frey M. The treatment of hand burns. Burns 2009; 35:327.</a></li><li><a class="nounderline abstract_t">Luce EA. The acute and subacute management of the burned hand. Clin Plast Surg 2000; 27:49.</a></li><li><a class="nounderline abstract_t">Scott JR, Costa BA, Gibran NS, et al. Pediatric palm contact burns: a ten-year review. J Burn Care Res 2008; 29:614.</a></li><li><a class="nounderline abstract_t">Rutan RL. Management of perineal and genital burns. J ET Nurs 1993; 20:169.</a></li><li><a class="nounderline abstract_t">Shin JY, Yi HS. Diagnostic accuracy of laser Doppler imaging in burn depth assessment: Systematic review and meta-analysis. Burns 2016; 42:1369.</a></li><li><a class="nounderline abstract_t">Jaspers MEH, van Haasterecht L, van Zuijlen PPM, Mokkink LB. A systematic review on the quality of measurement techniques for the assessment of burn wound depth or healing potential. Burns 2019; 45:261.</a></li><li><a class="nounderline abstract_t">Bell PL, Gabriel V. Evidence based review for the treatment of post-burn pruritus. J Burn Care Res 2009; 30:55.</a></li><li><a class="nounderline abstract_t">Anzarut A, Olson J, Singh P, et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 2009; 62:77.</a></li></ol></div><div id="topicVersionRevision">Topic 114176 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hartford CE, Kealey GP. Care of outpatient burns. In: Total Burn Care, Third edition, Herndon, DN (Eds), 2007. p.67.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6632013" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hypertrophic burn scars: analysis of variables.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16901651" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2335557" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hospital and prehospital resources for optimal care of patients with burn injury: guidelines for development and operation of burn centers. American Burn Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2335557" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Hospital and prehospital resources for optimal care of patients with burn injury: guidelines for development and operation of burn centers. American Burn Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19325318" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Understanding and managing burn pain: part 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19411907" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Understanding and managing burn pain: Part 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885244" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885244" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358554" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Topical treatment of pediatric patients with burns: a practical guide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358554" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Topical treatment of pediatric patients with burns: a practical guide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17636835" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Topical negative pressure (TNP) for partial thickness burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18843629" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Dressings for superficial and partial thickness burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16984440" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Proteolytic activity in human burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10741585" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A review on the nonoperative removal of necrotic tissue from burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15555800" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464480" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Enzymatic debridement of burn wound with collagenase in children with partial-thickness burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16566539" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Management of blisters in the partial-thickness burn: an integrative research review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18316972" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Prevention and management of infections associated with burns in the combat casualty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18849850" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The role of allogenic amniotic membrane in burn treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9177900" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17825993" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Bioengineered skin substitutes for the management of burns: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30635844" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : ReCell®Spray-On Skin System for Treating Skin Loss, Scarring and Depigmentation after Burn Injury: A NICE Medical Technology Guidance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31696127" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Comparative effectiveness of Biobrane®, RECELL®Autologous skin Cell suspension and Silver dressings in partial thickness paediatric burns: BRACS randomised trial protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15640725" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Primer on the management of face burns at the University of Washington.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18538480" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Topical management of facial burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Early management of the burned auricle</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1396185" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Chondritis of the burned ear: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1396185" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Chondritis of the burned ear: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18971859" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : [Ocular burns].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19801123" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The use of skin substitutes in hand burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18952379" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The treatment of hand burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10665355" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The acute and subacute management of the burned hand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18535472" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pediatric palm contact burns: a ten-year review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8343557" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Management of perineal and genital burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27215151" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diagnostic accuracy of laser Doppler imaging in burn depth assessment: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29941159" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A systematic review on the quality of measurement techniques for the assessment of burn wound depth or healing potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19060768" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Evidence based review for the treatment of post-burn pruritus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18249046" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
